Showing results (561-570 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893Anusha Kalbasi, Ester Fonsatti, Pier Giorgio Natali, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2bJohn A Craddock, An Lu, Adham Bear, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Preclinical qualification of a new multi-antigen candidate vaccine for metastatic melanomaThorsten U Vogel, Lucian Visan, Belma Ljutic, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patientsKarīna Siliņa, Pavel Zayakin, Zane Kalniņa, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitroMark A DeBenedette, David M Calderhead, Irina Y Tcherepanova, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horsesJessika- M V Müller, Karsten Feige, Patrizia Wunderlin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in miceErik E Johnson, Ilia N Buhtoiarov, Mark J Baldeshwiler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cellsChristoph Röllig, Christian Schmidt, Martin Bornhäuser, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapyPeter A Prieto, Katherine H Durflinger, John R Wunderlich, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cellsChristine Grabrucker, Anja Liepert, Julia Dreyig, et al.Pageof 176